Prostin F2 Alpha is a medicine containing the active ingredient(s) dinoprost. On this page you will find out more about Prostin F2 Alpha, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: dinoprost
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Prostin F2 Alpha 40 mg/8 mL injection solution, 8 mL ampoule
Consumer Medicine Information leaflet:
No consumer medicine information leaflet was found for the pack size you selected. It may be unavailable or there may be a technical problem. You should speak to your pharmacist, healthcare professional, or call healthdirect on 1800 022 222 for more information.
What this medicine is for
INDICATIONS AS AT 25 MAY 2005 : Therapeutic termination of pregnancy (PROSTIN F2 alpha Sterile Solution 5 mg/mL). 1. PROSTIN F2 alpha is indicated for the therapeutic termination of pregnancy during the first or second trimester. 2. PROSTIN F2 alpha may be used for evacuation of the uterus in cases of foetal death in utero, missed abortion, as a non-surgical treatment for the evacuation of hydatidiform moles and as an alternative measure to complete therapeutic termination of pregnancy when intra-amniotic saline injections have failed. NOTE: At the present time, this product should only be used in hospitals or in locations with facilities for emergency obstetric and gynaecological care.
Table of characteristics
|Visual appearance||Clear colourless solution|
|Dosage Form||Injection, solution|
|Route of administration||Intrauterine|
8mL X 1: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||No information available|
|Life time||5 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.